Recombinant Mouse Vascular endothelial growth factor D (Figf)

中文名稱：

小鼠Vegfd重組蛋白
貨號：

CSB-YP008674MO
規格：
來源：

Yeast
其他：

中文名稱：

小鼠Vegfd重組蛋白
貨號：

CSB-EP008674MO
規格：
來源：

E.coli
其他：

中文名稱：

小鼠Vegfd重組蛋白
貨號：

CSB-EP008674MO-B
規格：
來源：

E.coli
共軛：

Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
其他：

中文名稱：

小鼠Vegfd重組蛋白
貨號：

CSB-BP008674MO
規格：
來源：

Baculovirus
其他：

中文名稱：

小鼠Vegfd重組蛋白
貨號：

CSB-MP008674MO
規格：
來源：

Mammalian cell
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

純度：

>85% (SDS-PAGE)
基因名：

Vegfd
Uniprot No.：

P97946
別名：

Vegfd; Figf; Vascular endothelial growth factor D; VEGF-D; c-Fos-induced growth factor; FIGF
種屬：

Mus musculus (Mouse)
蛋白長度：

Full Length of Mature Protein
表達區域：

94-210
氨基酸序列

FAATFYD TETLKVIDEE WQRTQCSPRE TCVEVASELG KTTNTFFKPP CVNVFRCGGC CNEEGVMCMN TSTSYISKQL FEISVPLTSV PELVPVKIAN HTGCKCLPTG PRHPYSIIRR
蛋白標簽：

Tag?type?will?be?determined?during?the?manufacturing?process.

The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
產品提供形式：

Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
復溶：

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
儲存條件：

Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
保質期：

The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
貨期：

Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
注意事項：

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet ：

Please contact us to get it.

產品評價

靶點詳情

功能：

Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-3 (Flt4) receptor.
基因功能參考文獻：
1. lymphangiogenesis is regulated by two distinct proteolytic mechanisms of ligand activation: one in which VEGFC activation by ADAMTS3 and CCBE1 spatially and temporally patterns developing lymphatics, and one in which VEGFD activation by a distinct proteolytic mechanism may be stimulated during inflammatory lymphatic growth PMID: 27159393
2. This study uncovers a reciprocal relationship between dendrite geometry, the ability to generate nuclear calcium transients in response to synaptic inputs, and the subsequent induction of expression of plasticity-related and dendritic structure-preserving genes. Insufficient nuclear calcium signaling in CA1 hippocampal neurons and, consequently, reduced expression of the nuclear calcium target gene VEGFD. PMID: 28626015
3. Overexpression of VEGFD causes lymphatic hyperplasia in lung, kidney, and brown adipose tissue. Overexpression of VEGFD in white adipose tissue causes a de novo lymphatic network. PMID: 27342876
4. Vegf-d promotes oedema in response to hyperoxia in mice and support the hypothesis that VEGF-D signalling promotes vascular leak in human hyperoxic acute lung injury (HALI). PMID: 26924464
5. VEGF-D may be beneficial in early-stage tumors since it suppresses the pro-tumorigenic inflammation, while at later stages VEGF-D-induced tumor lymphatics provide a route for metastasis. PMID: 27435926
6. These results suggest that lymph node lymphangiogenesis occurs before metastasis in OSCC. VEGF-A and VEGF-D play critical roles in this process. PMID: 26630663
7. Results provided evidence that IL-7/IL-7R induce VEGF-D upregulation and promote lymphangiogenesis via c-Fos/c-Jun pathway in lung cancer. PMID: 24115038
8. Epidermal keratinocyte proliferation in vitro was not affected by VEGF-C or VEGF-D. PMID: 23695550
9. Neutrophils contribute to lymphangiogenesis primarily by modulating VEGF-A bioavailability and bioactivity and, to a lesser extent, secreting VEGF-D. Neutrophils increased VEGF-A bioavailability and bioactivity via the secretion of MMP9 and heparanase. PMID: 24113869
10. Vegf-d deficiency alters the caliber of initial lymphatics in the dermis leading to reduced functional capacity. PMID: 23439394
11. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. PMID: 22932121
12. VEGF-D has a role in progestin-induced break-through bleeding in thin-walled blood and lymphatic endometrial vessels PMID: 22383980
13. nuclear calcium-VEGFD signaling mediates the effect of neuronal activity on the maintenance of dendritic arbors in the adult hippocampus and is required for cognitive functioning. PMID: 21745642
14. Data show that that OUBC induces profound lymphangiogenesis in the tumor and SLN and substantial lymphatic metastasis to SLN through VEGF-C/D-VEGFR-3 signaling pathway. PMID: 21481239
15. VEGF-D over-expression has differential effects on the uterine vasculature. These effects may facilitate VEGF-D's ability to promote endometrial cancer metastasis and disease progression. PMID: 20615255
16. We investigated the expression of IEGs, including c-fos, fos-B, c-jun and dusp-1 mRNA, in the mouse heart after a once-daily methamphetamine injection for 1day, 2 or 4weeks. PMID: 19828354
17. These results show that VEGF-C/-D together with its receptor VEGFR-3 provides an auto-/paracrine growth and chemotactic system for glial precursors in the developing brain. PMID: 19646499
18. there are unique temporal and spatial expressions of VEGF-D isoforms during lung development which related factors have distinct functions in vascular and lymphatic patterning of the lung PMID: 12112468
19. VEGF-D promotes tumor angiogenesis, lymphangiogenesis and metastatic spread by a paracrine mechanism PMID: 12148568
20. study demonstrated that beta-catenin negative regulation is on theessenger vascular endothelial growth factor-D mRNA 3'-untranslated region PMID: 12920128
21. VEGF-C and VEGF-D are ligands for the integrin alpha9beta1 PMID: 15590642
22. The lack of a profound lymphatic phenotype in Vegf-d-deficient mice suggests that Vegf-d does not play a major role in lymphatic development. PMID: 15743836
23. VEGF-D/VEGFR-3 signaling plays a critical role in osteoblast maturation PMID: 16624815
24. results suggest the presence of lymphatic capillaries throughout the skeletal muscle, and present the localisation of VEGF-C and -D in the muscles. PMID: 16924525
25. in binding VEGFR-2, furin and PC5 promote cleavage of N-and C-terminal VEGF-D propeptides, whereas PC7 promotes cleavage of the C-terminal propeptide only PMID: 17242158
26. Diabetes increased the expression of VEGF-D in skeletal muscle. VEGF-D levels were not changed either in healthy or in diabetic muscle after the exercise training. PMID: 17766486
27. The expression of VEGF-D in the marginal portion of tumor significantly associated with lymphatic metastasis and prognosis in patients with pancreatic adenocarcinoma and may induced lymphangiogenesis. PMID: 18061373
28. Expression of VEGF-D is involved in growth and lymphatic spread of HCC. Therefore, VEGF-D might represent a therapeutic target in HCC. PMID: 18338756
29. These results suggest VEGF-C- and VEGF-D-independent functions for VEGFR-3 in the early embryo. PMID: 18519586
30. These data do not support an important role of VEGF-D in (lymph) angiogenesis or in adipose tissue development. PMID: 19022221
31. VEGF-C, -D, and -A derived from the CD11b+/Gr-1+ macrophages and local inflamed tissues play a critical role in promoting antigen clearance and inflammation resolution. PMID: 19346498
32. Long-term expression of VEGF-C and VEGF-D in skeletal muscle results in the generation of new functional blood and lymphatic vessels. PMID: 19443835
顯示更多

收起更多
亞細胞定位：

Secreted.
蛋白家族：

PDGF/VEGF growth factor family
組織特異性：

Highly expressed in fetal and adult lung.
數據庫鏈接：

KEGG: mmu:14205

STRING: 10090.ENSMUSP00000033751

UniGene: Mm.297978